Drug
cladribine
Marketed as MAVENCLAD.
Generic name
cladribine
Brand names
MAVENCLAD
First FDA approval
2019-03-29
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA022561 | MAVENCLAD | 2019-03-29 | EMD SERONO INC |
Manufacturers
EMD SERONO INC
Frequently asked questions
When was cladribine FDA approved?
Earliest FDA approval on record: 2019-03-29.
What brand names are sold as cladribine?
MAVENCLAD.
Sources
Appeal a cladribine denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com